Femasys Inc

Femasys Inc (FEMY) priced its initial public offering on Jun 21, 2021 at $13.00 per share, within its $12.00–$14.00 range, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $152.9M. Chardan was lead-left underwriter. Dechert advised the company and Goodwin Procter advised the underwriters.

Femasys Inc. is a biomedical company developing minimally invasive, non-surgical products for women's healthcare that can be used in the doctor's office. It addresses underserved areas of women's health and manufactures its devices in-house.

Status

IPO

Ticker

FEMY

Exchange

Nasdaq Capital Market

Priced

Jun 21, 2021

IPO price

$13.00

Price range

$12.00–$14.00

Market cap at IPO price

$152.9M

First filed

May 14, 2021

Underwriters

Chardan

Company counsel

Dechert

Underwriters' counsel

Goodwin Procter

Sector

Healthcare

Country / state

GA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.